126602-89-9 (奎奴普丁-甲磺酸达福普汀复合物,Streptogramin)

达福普丁甲磺酸复合物;奎奴普丁-甲磺酸达福普汀复合物;

Streptogramin;QUINUPRISTIN-DALFOPRISTIN MESYLATE COMPLEX;N-{(6S,9S,10R,13S,18R,22S,24aS)-18-{[(3S)-1-azabicyclo[2.2.2]oct-3-ylsulfanyl]methyl}-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl}-3-hydroxypyridine-2-carboxamide - (3R,4R,5Z,10Z,12Z,14S,26R)-26-{[2-(diethylamino)ethyl]sulfonyl}-14-hydroxy-4,12-dimethyl-3-(propan-2-yl)-8,9,14,15,24,25,26,26a-oc;SYNERCID;Quinupristin-dalfopristin;Mixture with quinupristin;Synercid coMplex, Dalfopristin-Quinupristin coMplex;126602-89-9;Quinupristin and dalfopristin;

PPKJUHVNTMYXOD-CEHYXHNTSA-N

1S/C53H67N9O10S.C34H50N4O9S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46;1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65);9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b;10-9-,12-11-,23-18-/t31-,35+,37-,38+,39?,40+,43-,44+,45+;24-,25-,28-,31-,32-/m11/s1

S(C[C@H]1C(CC2C(N[C@H](C(=O)O[C@H](C)[C@@H](C(N[C@H](CC)C(N3CCC[C@H]3C(N(C)[C@@H](CC3C=CC(=CC=3)N(C)C)C(N2C1)=O)=O)=O)=O)NC(C1C(=CC=CN=1)O)=O)C1C=CC=CC=1)=O)=O)[C@@H]1CN2CCC1CC2.S(CCN(CC)CC)([C@@H]1CCN2C(C3=COC(CC(C[C@@H](C=C(C)C=CCNC(C=C[C@@H](C)[C@@H](C(C)C)OC([C@H]21)=O)=O)O)=O)=N3)=O)(=O)=O |c:104,109,t:101|